Personal tools

Coexpression cluster:C4603: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C4603_non_acute_Hodgkin_chronic_Placental_thymus_rhabdomyosarcoma |id=C4603 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C4603_non_acute_Hodgkin_chronic_Placental_thymus_rhabdomyosarcoma
|full_id=C4603_non_acute_Hodgkin_chronic_Placental_thymus_rhabdomyosarcoma
|id=C4603
|id=C4603
|ontology_enrichment_celltype=CL:0000144!1.93e-12!625;CL:0002371!1.16e-11!591;CL:0000003!6.57e-11!722;CL:0000548!6.76e-11!679;CL:0000004!6.76e-11!679;CL:0000255!6.76e-11!679;CL:0000012!1.75e-10!682;CL:0000222!2.00e-10!119;CL:0000183!1.38e-08!59;CL:0000192!7.33e-08!42;CL:0000514!7.33e-08!42;CL:0000680!1.67e-07!57;CL:0000056!1.67e-07!57;CL:0000355!1.67e-07!57;CL:0000763!1.81e-07!112;CL:0000049!1.81e-07!112;CL:0000187!2.54e-07!54;CL:0000055!9.47e-07!180
|ontology_enrichment_disease=DOID:1240!2.21e-16!39;DOID:2531!1.94e-15!51;DOID:0060083!1.94e-15!51;DOID:8692!7.30e-14!31
|ontology_enrichment_uberon=UBERON:0003081!5.07e-12!216;UBERON:0004535!5.38e-10!110;UBERON:0001009!8.93e-10!113;UBERON:0004872!1.78e-08!84;UBERON:0002049!2.99e-08!79;UBERON:0007798!2.99e-08!79;UBERON:0001981!6.68e-08!60;UBERON:0007500!6.68e-08!60;UBERON:0004537!6.68e-08!60;UBERON:0006965!6.68e-08!60;UBERON:0003914!2.27e-07!118;UBERON:0000055!3.39e-07!69
}}
}}

Revision as of 14:50, 21 May 2012


Full id: C4603_non_acute_Hodgkin_chronic_Placental_thymus_rhabdomyosarcoma



Phase1 CAGE Peaks

Hg19::chr6:41909466..41909520,-p1@CCND3
Hg19::chr6:41909533..41909560,-p3@CCND3
Hg19::chr6:41909561..41909621,-p4@CCND3


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
somatic cell1.16e-11591
native cell6.57e-11722
animal cell6.76e-11679
eukaryotic cell6.76e-11679
mesodermal cell2.00e-10119
contractile cell1.38e-0859
smooth muscle cell7.33e-0842
smooth muscle myoblast7.33e-0842
muscle precursor cell1.67e-0757
myoblast1.67e-0757
multi-potent skeletal muscle stem cell1.67e-0757
myeloid cell1.81e-07112
common myeloid progenitor1.81e-07112
muscle cell2.54e-0754
non-terminally differentiated cell9.47e-07180
Uber Anatomy
Ontology termp-valuen
lateral plate mesoderm5.07e-12216
cardiovascular system5.38e-10110
circulatory system8.93e-10113
splanchnic layer of lateral plate mesoderm1.78e-0884
vasculature2.99e-0879
vascular system2.99e-0879
blood vessel6.68e-0860
epithelial tube open at both ends6.68e-0860
blood vasculature6.68e-0860
vascular cord6.68e-0860
epithelial tube2.27e-07118
vessel3.39e-0769
Disease
Ontology termp-valuen
leukemia2.21e-1639
hematologic cancer1.94e-1551
immune system cancer1.94e-1551
myeloid leukemia7.30e-1431


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.